← Back to headlines
Study Examines Limited Heart Health Benefits of Weight Loss Drugs in First Year
A BMJ study suggests that weight loss drugs offer limited heart health benefits in their first year of use, prompting experts to caution that it is too soon for a final verdict. The research also decodes the strengths and weaknesses of 19 GLP-1 drugs regarding weight loss, muscle mass, and heart risk.
9 Jul, 08:24 — 9 Jul, 09:02
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
indian-express
Center
Right1
Right (1)
hindustan-times
Far R
Geographic diversity— 1 region4/34
India2
ℹAll sources from India region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
indian-expressMostly Factual31d ago
BMJ study says weight loss drugs have limited heart health benefits in 1st year: Expert says too soon for a final verdict
Read full article →hindustan-timesMostly Factual31d ago
Weight loss, muscle mass, heart risk: Study decodes strengths & weaknesses of 19 GLP-1 drugs
Tirzepatide burns most fat and muscle; semaglutide cuts death, heart attack and kidney risk, and jury is out on whether they improve quality of life
Read full article →Coverage Timeline
First report: hindustan-times · 9 Jul, 08:24|Full coverage: 2 · 37m|Window: 37m
Left-leaningCenterRight-leaning
Related Stories
Recipe for a Healthy Gut: 30 Different Products Per Week Work Wonders
25m ago
Sales of Suspected PFAS Pesticide Rise in Denmark Amid Contamination Fears
26m ago
Mosquitoes Consciously Choose Hosts Based on Skin Secretions and Microorganisms
34m ago
WHO Recommends Clinical Trial for Ebola Vaccine Against Bundibugyo Virus
35m ago